Main menu

Portable 16S rRNA sequencing for antimicrobial stewardship


Anna Smielewska completed her medical training and PhD at the University of Cambridge and joined the Virology team at the Royal Liverpool Hospital as a consultant in 2021. She has been the Clinical Director and R&D lead for Infection and Immunity since 2022. Anna’s clinical and research interests are infections in the immunosuppressed and paediatrics. She works at both Clatterbridge Cancer Hospital and Alder Hey Paediatric Hospital and holds an Honorary Senior Lecturer post with the University of Liverpool.

Abstract

Rapid identification of microbiological organisms is especially important in today’s healthcare setting as we face increased antimicrobial resistance. Diagnostically there is a clear need for a rapid, accurate and flexible bacterial identification assay that could be run in a routine diagnostic laboratory, while remaining cost effective and lean.

Authors: Anna Smielewska, Clinical Director, Royal Liverpool Hospitals NHS Foundation Trust

入門

MinION Starter Packを購入 ナノポア製品の販売 シークエンスサービスプロバイダー グローバルディストリビューター

お問い合わせ

Intellectual property Cookie policy Corporate reporting Privacy policy Terms & conditions Accessibility

Oxford Nanoporeについて

Contact us 経営陣 メディアリソース & お問い合わせ先 投資家向け Oxford Nanopore社で働く BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Japanese flag